FDA Inspection 1180781 — Novum Pharmaceutical Research Services Inc
The FDA completed an inspection of Novum Pharmaceutical Research Services Inc on Sep 16, 2022 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Las Vegas, NV (United States)
Additional Details
Clinical BA/BE